{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T16:56:13Z","timestamp":1783702573099,"version":"3.55.0"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T00:00:00Z","timestamp":1652659200000},"content-version":"vor","delay-in-days":135,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["EXPL\/MED-FAR\/0203\/2021"],"award-info":[{"award-number":["EXPL\/MED-FAR\/0203\/2021"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Research in Toxicology"],"published-print":{"date-parts":[[2022]]},"DOI":"10.1016\/j.crtox.2022.100075","type":"journal-article","created":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T02:28:56Z","timestamp":1652927336000},"page":"100075","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["A review on the mitochondrial toxicity of \u201cecstasy\u201d (3,4-methylenedioxymethamphetamine, MDMA)"],"prefix":"10.1016","volume":"3","author":[{"given":"Jo\u00e3o Paulo","family":"Capela","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F\u00e9lix Dias","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.crtox.2022.100075_b0005","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.neuroscience.2008.10.041","article-title":"Acetyl-L-carnitine provides effective in vivo neuroprotection over 3,4-methylenedioximethamphetamine-induced mitochondrial neurotoxicity in the adolescent rat brain","volume":"158","author":"Alves","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.crtox.2022.100075_b0010","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1369-1600.2008.00143.x","article-title":"Ecstasy-induced oxidative stress to adolescent rat brain mitochondria in vivo: influence of monoamine oxidase type A","volume":"14","author":"Alves","year":"2009","journal-title":"Addict. Biol."},{"issue":"38","key":"10.1016\/j.crtox.2022.100075_b0015","doi-asserted-by":"crossref","first-page":"10203","DOI":"10.1523\/JNEUROSCI.2645-07.2007","article-title":"Monoamine oxidase-B mediates ecstasy-induced neurotoxic effects to adolescent rat brain mitochondria","volume":"27","author":"Alves","year":"2007","journal-title":"J. Neurosci."},{"issue":"10","key":"10.1016\/j.crtox.2022.100075_b0020","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1007\/s00204-015-1478-9","article-title":"Mitochondria: key players in the neurotoxic effects of amphetamines","volume":"89","author":"Barbosa","year":"2015","journal-title":"Arch. Toxicol."},{"issue":"2","key":"10.1016\/j.crtox.2022.100075_b0025","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s00204-013-1120-7","article-title":"The mixture of \u201cecstasy\u201d and its metabolites is toxic to human SH-SY5Y differentiated cells at in vivo relevant concentrations","volume":"88","author":"Barbosa","year":"2014","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.crtox.2022.100075_b0030","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/toxsci\/kfu042","article-title":"The mixture of \u201cecstasy\u201d and its metabolites impairs mitochondrial fusion\/fission equilibrium and trafficking in hippocampal neurons, at in vivo relevant concentrations","volume":"139","author":"Barbosa","year":"2014","journal-title":"Toxicol. Sci."},{"issue":"8","key":"10.1016\/j.crtox.2022.100075_b0035","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1007\/s00204-014-1209-7","article-title":"MDMA impairs mitochondrial neuronal trafficking in a Tau- and Mitofusin2\/Drp1-dependent manner","volume":"88","author":"Barbosa","year":"2014","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.crtox.2022.100075_b0040","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.neuropharm.2015.01.025","article-title":"Contribution of dopamine to mitochondrial complex I inhibition and dopaminergic deficits caused by methylenedioxymethamphetamine in mice","volume":"93","author":"Barros-Mi\u00f1ones","year":"2015","journal-title":"Neuropharmacology"},{"issue":"6","key":"10.1016\/j.crtox.2022.100075_b0045","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1038\/npp.2013.331","article-title":"Evidence for a role of transporter-mediated currents in the depletion of brain serotonin induced by serotonin transporter substrates","volume":"39","author":"Baumann","year":"2014","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"10.1016\/j.crtox.2022.100075_b0050","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.2215\/CJN.02080508","article-title":"The agony of ecstasy: MDMA (3,4-methylenedioxymethamphetamine) and the kidney","volume":"3","author":"Campbell","year":"2008","journal-title":"Cin J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.crtox.2022.100075_b0055","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/s12035-009-8064-1","article-title":"Molecular and cellular mechanisms of ecstasy-induced neurotoxicity: an overview","volume":"39","author":"Capela","year":"2009","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.crtox.2022.100075_b0060","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.neuro.2012.09.005","article-title":"The neurotoxicity of hallucinogenic amphetamines in primary cultures of hippocampal neurons","volume":"34","author":"Capela","year":"2013","journal-title":"Neurotoxicology"},{"issue":"4","key":"10.1016\/j.crtox.2022.100075_b0065","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1016\/j.neuroscience.2007.03.028","article-title":"Neurotoxicity mechanisms of thioether ecstasy metabolites","volume":"146","author":"Capela","year":"2007","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.crtox.2022.100075_b0070","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1124\/jpet.105.092577","article-title":"Neurotoxicity of Ecstasy metabolites in rat cortical neurons, and influence of hyperthermia","volume":"316","author":"Capela","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"8","key":"10.1016\/j.crtox.2022.100075_b0075","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1007\/s00204-012-0815-5","article-title":"Toxicity of amphetamines: an update","volume":"86","author":"Carvalho","year":"2012","journal-title":"Arch. Toxicol."},{"issue":"5","key":"10.1016\/j.crtox.2022.100075_b0080","doi-asserted-by":"crossref","first-page":"802","DOI":"10.4103\/1673-5374.268895","article-title":"Neuronal and peripheral damages induced by synthetic psychoactive substances: an update of recent findings from human and animal studies","volume":"15","author":"Costa","year":"2020","journal-title":"Neural Regen. Res."},{"issue":"9","key":"10.1016\/j.crtox.2022.100075_b0085","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1021\/tx400130v","article-title":"The heart as a target for xenobiotic toxicity: the cardiac susceptibility to oxidative stress","volume":"26","author":"Costa","year":"2013","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.crtox.2022.100075_b0090","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1111\/j.1360-0443.2009.02649.x","article-title":"Test-re-test reliability of DSM-IV adopted criteria for 3,4-methylenedioxymethamphetamine (MDMA) abuse and dependence: a cross-national study","volume":"104","author":"Cottler","year":"2009","journal-title":"Addiction"},{"issue":"2-3","key":"10.1016\/j.crtox.2022.100075_b0095","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.tox.2010.01.022","article-title":"Comparative effects of 3,4-methylenedioxymethamphetamine and 4-methylthioamphetamine on rat liver mitochondrial function","volume":"270","author":"Cust\u00f3dio","year":"2010","journal-title":"Toxicology"},{"issue":"2","key":"10.1016\/j.crtox.2022.100075_b0105","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1046\/j.1365-2125.2000.00121.x","article-title":"Non-linear pharmacokinetics of MDMA ('ecstasy') in humans","volume":"49","author":"De La Torre","year":"2000","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.crtox.2022.100075_b0110","doi-asserted-by":"crossref","DOI":"10.1097\/00007691-200404000-00009","article-title":"Human pharmacology of MDMA: pharmacokinetics, metabolism, and disposition","volume":"26","author":"de la Torre","year":"2004","journal-title":"Therapeutic Drug Monitor"},{"issue":"4","key":"10.1016\/j.crtox.2022.100075_b0115","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1192\/bjp.bp.106.035089","article-title":"Neurotoxic effects of ecstasy on the thalamus","volume":"193","author":"de Win","year":"2008","journal-title":"Br. J. Psychiatry"},{"issue":"12","key":"10.1016\/j.crtox.2022.100075_b0120","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1007\/s00204-013-1082-9","article-title":"An insight into the hepatocellular death induced by amphetamines, individually and in combination: the involvement of necrosis and apoptosis","volume":"87","author":"Dias da Silva","year":"2013","journal-title":"Arch. Toxicol."},{"issue":"6","key":"10.1016\/j.crtox.2022.100075_b0100","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/jat.2889","article-title":"Combination effects of amphetamines under hyperthermia - the role played by oxidative stress","volume":"34","author":"Dias da Silva","year":"2014","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.crtox.2022.100075_b0125","series-title":"European Drug Report 2021: Trends and Developments, in","author":"EMCDDA","year":"2021"},{"issue":"6","key":"10.1016\/j.crtox.2022.100075_b0130","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1001\/archgenpsychiatry.2011.56","article-title":"In vivo imaging of cerebral serotonin transporter and Serotonin2A receptor binding in 3,4-methylenedioxymethamphetamine (MDMA or \u201cEcstasy\u201d) and hallucinogen users","volume":"68","author":"Erritzoe","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"issue":"3","key":"10.1016\/j.crtox.2022.100075_b0135","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s00213-002-1261-5","article-title":"Pharmacological characterization of the effects of 3,4-methylenedioxymethamphetamine (\u201cecstasy\u201d) and its enantiomers on lethality, core temperature, and locomotor activity in singly housed and crowded mice","volume":"166","author":"Fantegrossi","year":"2003","journal-title":"Psychopharmacology"},{"issue":"7","key":"10.1016\/j.crtox.2022.100075_b0140","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1007\/s00204-018-2226-8","article-title":"Aged rats are more vulnerable than adolescents to \u201cecstasy\u201d-induced toxicity","volume":"92","author":"Feio-Azevedo","year":"2018","journal-title":"Arch. Toxicol."},{"issue":"2-3","key":"10.1016\/j.crtox.2022.100075_b0145","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.toxlet.2012.11.015","article-title":"Neurotoxicity of \u201cecstasy\u201d and its metabolites in human dopaminergic differentiated SH-SY5Y cells","volume":"216","author":"Ferreira","year":"2013","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.crtox.2022.100075_b0150","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1111\/j.1360-0443.2006.01511.x","article-title":"The origin of MDMA (ecstasy) revisited: the true story reconstructed from the original documents","volume":"101","author":"Freudenmann","year":"2006","journal-title":"Addiction"},{"key":"10.1016\/j.crtox.2022.100075_b0155","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1034\/j.1600-0773.2002.910105.x","article-title":"Ecstasy during loud noise exposure induces dramatic ultrastructural changes in the heart","volume":"91","author":"Gesi","year":"2002","journal-title":"Pharmacol. Toxicol."},{"key":"10.1016\/j.crtox.2022.100075_b0160","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1111\/j.1471-4159.2007.05042.x","article-title":"Minoxidil prevents 3,4-methylenedioxymethamphetamine-induced serotonin depletions: role of mitochondrial ATP-sensitive potassium channels, Akt and ERK","volume":"104","author":"Go\u00f1i-Allo","year":"2008","journal-title":"J Neurochem"},{"issue":"9186","key":"10.1016\/j.crtox.2022.100075_b0165","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/S0140-6736(99)02729-4","article-title":"Fatal uncertainty: death-rate from use of ecstasy or heroin","volume":"354","author":"Gore","year":"1999","journal-title":"The Lancet"},{"issue":"6","key":"10.1016\/j.crtox.2022.100075_b0170","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1093\/bja\/ael078","article-title":"Acute toxic effects of 'Ecstasy' (MDMA) and related compounds: overview of pathophysiology and clinical management","volume":"96","author":"Hall","year":"2006","journal-title":"Br. J. Anaesth."},{"issue":"1","key":"10.1016\/j.crtox.2022.100075_b0175","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.lfs.2013.07.014","article-title":"Neurotoxicity of methamphetamine and 3,4-methylenedioxymethamphetamine","volume":"97","author":"Halpin","year":"2014","journal-title":"Life Sci."},{"issue":"5","key":"10.1016\/j.crtox.2022.100075_b0180","doi-asserted-by":"crossref","first-page":"e36476","DOI":"10.1371\/journal.pone.0036476","article-title":"Duloxetine inhibits effects of MDMA (\u201cecstasy\u201d) in vitro and in humans in a randomized placebo-controlled laboratory study","volume":"7","author":"Hysek","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.crtox.2022.100075_b0185","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1021\/tx020029b","article-title":"Inhibition of the alpha-ketoglutarate dehydrogenase and pyruvate dehydrogenase complexes by a putative aberrant metabolite of serotonin, tryptamine-4,5-dione","volume":"15","author":"Jiang","year":"2002","journal-title":"Chem. Res. Toxicol."},{"issue":"2","key":"10.1016\/j.crtox.2022.100075_b0190","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.taap.2003.12.017","article-title":"Neurotoxicity of amphetamine derivatives is mediated by caspase pathway activation in rat cerebellar granule cells","volume":"196","author":"Jim\u00e9nez","year":"2004","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"1-2","key":"10.1016\/j.crtox.2022.100075_b0195","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.lfs.2014.02.010","article-title":"Elucidating the neurotoxic effects of MDMA and its analogs","volume":"101","author":"Karuppagounder","year":"2014","journal-title":"Life Sci."},{"issue":"7","key":"10.1016\/j.crtox.2022.100075_b0200","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1177\/0269881119844185","article-title":"Metabolites of the ring-substituted stimulants MDMA, methylone and MDPV differentially affect human monoaminergic systems","volume":"33","author":"Luethi","year":"2019","journal-title":"J. Psychopharmacol."},{"issue":"6965","key":"10.1016\/j.crtox.2022.100075_b0205","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/426403a","article-title":"Uncoupling the agony from ecstasy","volume":"426","author":"Mills","year":"2003","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.crtox.2022.100075_b0210","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/s41591-021-01336-3","article-title":"MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study","volume":"27","author":"Mitchell","year":"2021","journal-title":"Nat. Med."},{"issue":"9","key":"10.1016\/j.crtox.2022.100075_b0215","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1007\/s00213-019-05249-5","article-title":"MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials","volume":"236","author":"Mithoefer","year":"2019","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.crtox.2022.100075_b0220","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0925-4439(02)00112-6","article-title":"3,4-Methylenedioxymethamphetamine (\u201cEcstasy\u201d) induces apoptosis of cultured rat liver cells","volume":"1588","author":"Montiel-Duarte","year":"2002","journal-title":"Biochim. Biophys. Acta, Mol. Cell. Res."},{"key":"10.1016\/j.crtox.2022.100075_b0225","doi-asserted-by":"crossref","first-page":"3906","DOI":"10.1002\/pmic.200800215","article-title":"Mechanism of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy)-mediated mitochondrial dysfunction in rat liver","volume":"8","author":"Moon","year":"2008","journal-title":"Proteomics"},{"issue":"3","key":"10.1016\/j.crtox.2022.100075_b0230","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/jat.3351","article-title":"Cytotoxic effects of psychotropic benzofuran derivatives, N-methyl-5-(2-aminopropyl)benzofuran and its N-demethylated derivative, on isolated rat hepatocytes","volume":"37","author":"Nakagawa","year":"2017","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.crtox.2022.100075_b0235","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1046\/j.1471-4159.2001.00262.x","article-title":"Enhancement of 3,4-methylenedioxymethamphetamine neurotoxicity by the energy inhibitor malonate","volume":"77","author":"Nixdorf","year":"2001","journal-title":"J. Neurochem."},{"issue":"3","key":"10.1016\/j.crtox.2022.100075_b0240","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s00213-022-06086-9","article-title":"MDMA and memory, addiction, and depression: dose-effect analysis","volume":"239","author":"Pantoni","year":"2022","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.crtox.2022.100075_b0245","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/02791072.2015.1128580","article-title":"The history of MDMA as an underground drug in the United States, 1960\u20131979","volume":"48","author":"Passie","year":"2016","journal-title":"J. Psychoact. Drugs"},{"issue":"10","key":"10.1016\/j.crtox.2022.100075_b0250","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1038\/npp.2017.80","article-title":"3,4-Methylenedioxymethamphetamine Increases Affiliative Behaviors in Squirrel Monkeys in a Serotonin 2A Receptor-Dependent Manner","volume":"42","author":"Pitts","year":"2017","journal-title":"Neuropsychopharmacology"},{"issue":"11","key":"10.1016\/j.crtox.2022.100075_b0255","doi-asserted-by":"crossref","first-page":"e0166750","DOI":"10.1371\/journal.pone.0166750","article-title":"Non-serotonergic neurotoxicity by MDMA (Ecstasy) in neurons derived from mouse P19 embryonal carcinoma cells","volume":"11","author":"Popova","year":"2016","journal-title":"PLoS ONE"},{"issue":"2-3","key":"10.1016\/j.crtox.2022.100075_b0260","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ejphar.2010.06.019","article-title":"Involvement of mitochondrial\/lysosomal toxic cross-talk in ecstasy induced liver toxicity under hyperthermic condition","volume":"643","author":"Pourahmad","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.crtox.2022.100075_b0265","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/j.1471-4159.2008.05825.x","article-title":"Phosphodiesterase 5 inhibitors prevent 3,4-methylenedioxymethamphetamine-induced 5-HT deficits in the rat","volume":"108","author":"Puerta","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.crtox.2022.100075_b0270","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1476-5381.2010.00663.x","article-title":"Methylenedioxymethamphetamine inhibits mitochondrial complex I activity in mice: a possible mechanism underlying neurotoxicity","volume":"160","author":"Puerta","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.crtox.2022.100075_b0275","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.neubiorev.2017.07.015","article-title":"MDMA and brain activity during neurocognitive performance: An overview of neuroimaging studies with abstinent \u2018Ecstasy\u2019 users","volume":"84","author":"Roberts","year":"2018","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"2","key":"10.1016\/j.crtox.2022.100075_b0280","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1124\/jpet.104.079236","article-title":"The role of mitochondrial uncoupling in 3,4-methylenedioxymethamphetamine-mediated skeletal muscle hyperthermia and rhabdomyolysis","volume":"313","author":"Rusyniak","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.crtox.2022.100075_b0285","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.neuropharm.2013.11.008","article-title":"Monoamine transporter and receptor interaction profiles of a new series of designer cathinones","volume":"79","author":"Simmler","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.crtox.2022.100075_b0290","doi-asserted-by":"crossref","first-page":"434","DOI":"10.2174\/138920110791591436","article-title":"Mechanisms of MDMA (ecstasy)-induced oxidative stress, mitochondrial dysfunction, and organ damage","volume":"11","author":"Song","year":"2010","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.crtox.2022.100075_b0295","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1515\/bc.2011.016","article-title":"The ugly side of amphetamines: short- and long-term toxicity of 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy'), methamphetamine and D-amphetamine","volume":"392","author":"Steinkellner","year":"2011","journal-title":"Biol. Chem."},{"issue":"3","key":"10.1016\/j.crtox.2022.100075_b0300","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s00204-020-02673-x","article-title":"Dose concentration and spatial memory and brain mitochondrial function association after 3,4-methylenedioxymethamphetamine (MDMA) administration in rats","volume":"94","author":"Taghizadeh","year":"2020","journal-title":"Arch. Toxicol."},{"issue":"1","key":"10.1016\/j.crtox.2022.100075_b0305","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s12640-020-00183-3","article-title":"Bucladesine attenuates spatial learning and hippocampal mitochondrial impairments induced by 3, 4-methylenedioxymethamphetamine (MDMA)","volume":"38","author":"Taghizadeh","year":"2020","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.crtox.2022.100075_b0310","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.freeradbiomed.2016.07.018","article-title":"Protective effects of physical exercise on MDMA-induced cognitive and mitochondrial impairment","volume":"99","author":"Taghizadeh","year":"2016","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.crtox.2022.100075_b0315","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s40360-016-0070-0","article-title":"\u201cEcstasy\u201d toxicity to adolescent rats following an acute low binge dose","volume":"17","author":"Teixeira-Gomes","year":"2016","journal-title":"BMC Pharmacol Toxicol"},{"key":"10.1016\/j.crtox.2022.100075_b0320","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1385\/CT:5:3:301","article-title":"3,4-Methylenedioxymethamphetamine activates nuclear factor-kappaB, increases intracellular calcium, and modulates gene transcription in rat heart cells","volume":"5","author":"Tiangco","year":"2005","journal-title":"Cardiovasc. Toxicol."},{"key":"10.1016\/j.crtox.2022.100075_b0325","series-title":"World Drug Report 2021","author":"UNODC","year":"2021"},{"issue":"9","key":"10.1016\/j.crtox.2022.100075_b0330","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1093\/ndt\/gft023","article-title":"High incidence of mild hyponatraemia in females using ecstasy at a rave party","volume":"28","author":"van Dijken","year":"2013","journal-title":"Nephrol. Dial. Transplant."},{"issue":"7","key":"10.1016\/j.crtox.2022.100075_b0335","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/hup.529","article-title":"Acute, sub-acute and long-term subjective consequences of 'ecstasy' (MDMA) consumption in 430 regular users","volume":"18","author":"Verheyden","year":"2003","journal-title":"Hum. Psychopharmacol."},{"issue":"7","key":"10.1016\/j.crtox.2022.100075_b0340","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.3390\/ijms20071561","article-title":"Molecular toxicological mechanisms of synthetic cathinones on C2C12 myoblasts","volume":"20","author":"Zhou","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.crtox.2022.100075_b0345","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ejphar.2018.08.037","article-title":"3,4-Methylenedioxymethamphetamine, mephedrone, and \u03b2-phenylethylamine release dopamine from the cytoplasm by means of transporters and keep the concentration high and constant by blocking reuptake","volume":"837","author":"Zsilla","year":"2018","journal-title":"Eur. J. Pharmacol."}],"container-title":["Current Research in Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666027X22000123?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666027X22000123?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T10:18:21Z","timestamp":1762942701000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666027X22000123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":69,"alternative-id":["S2666027X22000123"],"URL":"https:\/\/doi.org\/10.1016\/j.crtox.2022.100075","relation":{},"ISSN":["2666-027X"],"issn-type":[{"value":"2666-027X","type":"print"}],"subject":[],"published":{"date-parts":[[2022]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A review on the mitochondrial toxicity of \u201cecstasy\u201d (3,4-methylenedioxymethamphetamine, MDMA)","name":"articletitle","label":"Article Title"},{"value":"Current Research in Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.crtox.2022.100075","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100075"}}